Difference between revisions of "Mannitol"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Category:Drug index" to "Category:Drugs") |
Warner-admin (talk | contribs) m (Text replacement - "[[Category:Drugs FDA" to "[[Category:FDA") |
||
| Line 12: | Line 12: | ||
[[Category:Intravenous medications]] | [[Category:Intravenous medications]] | ||
[[Category:Chemotherapy protective agents]] | [[Category:Chemotherapy protective agents]] | ||
| − | [[Category: | + | [[Category:FDA approved in 1965]] |
Revision as of 19:39, 30 July 2018
General information
Class/mechanism: Osmotic agent; increases circulating plasma volume
Route: IV
Extravasation: unknown
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information.
Diseases for which it is used
No known antineoplastic properties. Used for maintenance of plasma volume in certain chemotherapy protocols.